Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Chronic-Phase × lenvatinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 35 Parkinson Disease 4, Autosomal Dominant Lewy Body 26 Carcinoma, Renal Cell 21 Melanoma 10 Endometrial Neoplasms 10 Neoplasms 9 Cholangiocarcinoma 8 Biliary Tract Neoplasms 7 Uterine Cervical Neoplasms 6 Liver Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Triple Negative Breast Neoplasms 4 Thyroid Neoplasms 4 Stomach Neoplasms 4 Recurrence 4 Ovarian Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Neuroendocrine Tumors 3 Neoplasm Metastasis 3 Esophageal Squamous Cell Carcinoma 3 Diabetes Mellitus, Insulin-Dependent, 12 3 Breast Neoplasms 3 Adenocarcinoma 3 Vulvar Neoplasms 2 Uveal Melanoma 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Pancreatic Neoplasms 2 Kidney Neoplasms 2

Interventions

nilotinib 6 asciminib 6 Dasatinib 6 Imatinib Mesylate 5 bosutinib 4 Cyclophosphamide 4 fludarabine phosphate 3 Whole-Body Irradiation 3 ruxolitinib 2 ponatinib 2 letermovir 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Mycophenolic Acid 2 Methotrexate 2 Melphalan 2 Cyclosporine 2 Busulfan 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 olverembatinib 1 decitabine and cedazuridine drug combination 1 Vorinostat 1 Valganciclovir 1 Therapeutics 1 Stem Cell Transplantation 1 Specimen Handling 1 Sirolimus 1 Rituximab 1 Practice Management, Medical 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡